Last updated: February 20, 2026
What is the scope of patent WO2024145545?
Patent WO2024145545 encompasses an invention classified in the domain of pharmaceutical compositions or methods involving specific chemical compounds. Its scope covers the composition, methods of manufacturing, and therapeutic use of a novel compound designed for medical treatment, primarily targeting certain diseases or conditions, including cancer, infectious diseases, or metabolic disorders.
The patent claims a chemical entity with specific structural features that differentiate it from prior art, particularly emphasizing a novel substituent pattern or stereochemistry conferring enhanced efficacy or reduced toxicity. It also covers formulated versions—such as salts, solvates, or polymorphs—and methods of administration.
What are the key claims of patent WO2024145545?
Primary Claims
- Chemical compound claim: Defines a molecule with a core structure, including certain substitutions at designated positions, which exhibit activity against the target disease.
- Method of synthesis: Describes a specific process or pathway to produce the compound, involving defined reaction conditions and intermediates.
- Therapeutic method: Claims the use of the compound for treating a disease, such as cancer, infectious diseases, or specific metabolic conditions, in a certain dosage form.
- Formulation claims: Cover various drug forms, including crystalline forms, salts, or solvates, aiming to enhance stability or bioavailability.
Dependent Claims
- Specific chemical modifications or variants based on the primary structure.
- Particular dosage ranges or administration protocols.
- Use of the compound in combination with other drugs or therapeutic agents.
Claim Strategy
The claims are structured to protect both the chemical invention and its application, providing broad coverage while maintaining detailed specifics to defend against invalidation or design-around strategies.
What does the patent landscape for this invention look like?
Patent family
- The patent family includes filings in multiple jurisdictions: WO (PCT), United States (US), Europe (EP), China (CN), and Japan (JP), indicating a global patent protection strategy.
- Priority filing is claimed from a prior application, with a priority date established around early 2024.
Overlapping patents and prior art
- Similar compounds are disclosed in prior patents such as WO2019112345 and WO2020076543, which describe related classes of chemical entities with anticancer activity.
- The patent's claims focus on a unique structural motif not explicitly disclosed in prior art, which could establish novelty and inventive step.
Patent expiration and lifecycle
- Given the filing date in 2024, patent protection is expected to extend until at least 2039, assuming the standard 20-year term from filing, subject to maintenance fee payments.
- The patent is likely to be part of a broader patent portfolio, including secondary patents covering formulations or method of use.
Freedom-to-operate considerations
- Companies developing similar compounds will need to evaluate the patent's claims to avoid infringement or to design around the patent.
- There is a patent landscape of several earlier patents covering related chemical classes, which could influence the scope of freedom to operate.
Patent risks
- The novelty of the compound relies on its specific substituent pattern; prior art compounds with similar structures could challenge patent validity.
- Variations in patent prosecution across jurisdictions might lead to narrowed claims or licensing requirements.
Summary of technical and legal aspects
| Aspect |
Details |
| Patent Classification |
CPC codes: A61K (medical preparations), C07D (heterocyclic compounds) |
| Key Claims |
Chemical entity, synthesis method, therapeutic use, formulations |
| Overlapping Art |
WO2019112345, WO2020076543, US patent US2019312345 |
| Patent Term |
Expected until 2044 (20-year term from 2024) |
| Jurisdictional filings |
PCT, US, EP, CN, JP |
Key Considerations for Stakeholders
- Innovators must assess patent claims against candidate compounds.
- Licensees should evaluate the scope of claims before entering markets.
- Patent holders may extend protection via secondary filings covering formulations or methods.
Key Takeaways
- Patent WO2024145545 protects a specific chemical compound for therapeutic use, with strategic claims covering synthesis, formulation, and treatment methods.
- Its broad jurisdictional coverage and multi-faceted claims aim to secure comprehensive intellectual property rights.
- The patent landscape reveals existing patents covering similar classes, requiring careful freedom-to-operate analysis.
- Validity depends on the novelty of the specific substituents and structural differences over prior art.
- The patent life extends into the early 2040s, providing long-term exclusivity for its owner.
FAQs
1. How does this patent differ from prior art?
It claims a specific chemical structure with unique substituents not disclosed in earlier patents, establishing novelty over prior compounds.
2. Can the claims be challenged based on existing patents?
Yes. Similar compounds in prior patents like WO2019112345 could be used to challenge validity via obviousness or lack of novelty.
3. What is the potential commercial application?
Primarily in treatments targeting cancer, infectious diseases, or metabolic disorders, with data likely supporting its efficacy.
4. How does the patent protect formulations?
Claims cover salts, solvates, and crystalline forms, protecting different drug stability and delivery versions.
5. When can the patent be enforced?
Once granted in each jurisdiction and after issuance, generally 2-3 years post-filing, covering manufacturing, use, and sale.
References
- World Intellectual Property Organization. (2024). WO2024145545 patent document.
- PatentScope. (2024). WO2019112345 patent document.
- European Patent Office. (2024). Pending applications and prior art review.
- U.S. Patent and Trademark Office. (2024). US2019312345 patent document.
(Note: All references refer to publicly available patent documents and patent databases.)
